nivolumab,pembrolizumab
bms,merck
['mibc', 'nivolumab', ' rev ', 'cisplatin', 'urothelial', 'spare', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'carboplatin', 'nivo', 'gemcitabine', 'bladder']
fantastic overview by on mibc #gu23 &amp;eloquently highlights the need for further trials to answer clinically important q... sequencing: sac vs ev? io or ev-io vs surgery? will ev-io improve outcomes &gt;gc? adjuvant io+/- ev if pcr variant histologies? 
Medical oncologist @GACancerCenter, Augusta University specializing in genitourinary &breast oncology. Editor and TB moderator @themednet.org #patientadvocate